Efficacy and safety kaolin-based hemostatic pad vs. standard mechanical compression following transradial and transulnar access for elective coronary angiography and PCI

Not Applicable

• Conditions: I25; Chronic ischaemic heart disease

• Registration Number: DRKS00016159
• Lead Sponsor: 1Cardiology Department, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2017-08-03
• Study Start: 2018-12-28
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

Regardless of sex, patients who were at least 18 years of age and hospitalized for their first elective CAG (coronary angiography) were eligible for the trial.

Exclusion Criteria

Patients with upper limb anomalies and those who underwent prior vascular interventions (TRA or TUA) were excluded. The additional exclusion criteria were as follows: RA or UA < 1.5 mm based on ultrasonography and positive Allen’s test results.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Successful hemostasis without bleeding during hemostasis or after removal hemostatic device with no evidence of expanding forearm hematoma.

Secondary Outcome Measures

Name	Time	Method
Vascular complications, such as TAO (total artery occlusion), IPA (pseudoaneurysm) or large hematoma.